Position in HALO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$743,486
+$263,673 QoQ
Shares Held
9,499
+27.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#338
of 669 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vise Technologies, Inc. holds $19,918,588 across 31 Biotechnology names. HALO ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,882 | $3,915,225 | |
| 2 | RPRX |
Royalty Pharma plc
|
23,958 | $1,343,325 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,142 | $1,335,622 | |
| 4 | EXEL |
Exelixis, Inc.
|
15,708 | $854,672 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
9,366 | $814,373 | |
| 6 | INCY |
Incyte Corp
|
7,156 | $811,204 | |
| 7 | ARGX |
Argenx SE
|
834 | $773,760 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
This page
|
9,499 | $743,486 |
All Filings in HALO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $743,486 | 9,499 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $479,813 | 7,424 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $499,635 | 7,424 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||